JAAQ secures $17 million to integrate clinically approved mental health content.

      The London-based platform, which currently supports 1.5 million eligible lives through enterprise and healthcare deployments, is utilizing the Series A funding to speed up its entry into the US market and enhance its clinical infrastructure, with a new CEO who previously sold his company to Adobe.

      JAAQ, a digital health engagement platform located in London, has successfully raised $17 million in a Series A funding round. The investment, which comes from Meridian Health Ventures, Fuel Ventures, Bolt Angels, and Guinness Ventures, will be used to expand enterprise partnerships, strengthen clinical infrastructure, and enter the United States. As part of this deal, Dr. Pooja Sikka, a partner at Meridian Health Ventures, will join the company’s board.

      Founded in 2021, JAAQ initially operated on a direct-to-consumer model centered on video-based mental health content. However, it has since shifted to focus on enterprise and healthcare, integrating its library of over 10,000 clinically reviewed videos into the digital products of insurers, employers, and healthcare organizations instead of supplying it directly to individual users.

      The approach is structural: rather than requiring users to search for a mental health platform, JAAQ embeds its content into the applications and services they already utilize. The platform currently serves more than 1.5 million eligible lives through active enterprise deployments.

      Alex Packham has been appointed as CEO to guide the company through its next stage. Packham is recognized for founding ContentCal, a social media management SaaS platform that he sold to Adobe in December 2021, after which he spent three years overseeing its product integration within Adobe before leaving.

      JAAQ’s commercial offering consists of two components: organizations can either license content from JAAQ’s library to incorporate into their own user journeys or they can license a customized hosted JAAQ experience.

      Additionally, the company is developing what it terms a “clinical engagement layer” for AI-native products, allowing any digital product or team to incorporate regulated mental health content into user journeys without having to create their own clinical governance systems.

      The value proposition for enterprises addresses two simultaneous challenges: the gap in mental health access and the low engagement rates with wellbeing benefits that organizations invest in but employees seldom utilize.

      The framework of clinical governance is crucial to how JAAQ distinguishes itself from more generic AI wellness tools. The platform’s content is produced within a specific clinical and creative framework rather than generated on demand, and the appointment of Johri signifies that the product is being developed with inherent clinical credibility rather than as an afterthought.

      Meridian Health Ventures, which specifically targets UK health technology and aims for entry into the US market, aligns well with this positioning: the firm manages the first NHS-backed venture fund and has a dedicated Innovations in Mental Health Fund.

      The strategic priority of this funding is to facilitate US expansion. The UK market has validated the model, as the company’s website cites case studies, including a UK bank that saved £896,000 from improvements in employee productivity and wellbeing, and an insurer that equated to eliminating twelve full-time customer service roles through content provided by JAAQ.

      Translating this model to the US employer and health insurer market, where mental health benefits are increasingly prioritized at the board level yet engagement continues to be a challenge, presents the next significant test.